Greg Bondy

1.3k total citations
18 papers, 1.1k citations indexed

About

Greg Bondy is a scholar working on Emergency Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Greg Bondy has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Emergency Medicine, 4 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Greg Bondy's work include HIV-related health complications and treatments (7 papers), HIV/AIDS drug development and treatment (3 papers) and HIV Research and Treatment (2 papers). Greg Bondy is often cited by papers focused on HIV-related health complications and treatments (7 papers), HIV/AIDS drug development and treatment (3 papers) and HIV Research and Treatment (2 papers). Greg Bondy collaborates with scholars based in Canada, United States and Japan. Greg Bondy's co-authors include Allan B. Okey, Michelle E. Mason, D W Nebert, Howard J. Eisen, G. F. Kahl, Thomas M. Guenthner, Julio Montaner, Robert S. Hogg, Daniel W. Nebert and Cynthia Forster‐Gibson and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Greg Bondy

17 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Greg Bondy Canada 12 335 235 223 212 138 18 1.1k
Patricia C. Chulada United States 15 74 0.2× 227 1.0× 403 1.8× 135 0.6× 189 1.4× 22 2.2k
Zyanya Lucía Zatarain-Barrón Mexico 21 122 0.4× 231 1.0× 487 2.2× 48 0.2× 516 3.7× 59 1.5k
Martin Béliveau United States 18 60 0.2× 51 0.2× 180 0.8× 57 0.3× 61 0.4× 29 942
M H Thompson United Kingdom 27 124 0.4× 349 1.5× 404 1.8× 124 0.6× 561 4.1× 93 2.1k
Soundararajan Krishnaswamy United States 24 42 0.1× 127 0.5× 632 2.8× 453 2.1× 450 3.3× 34 1.7k
Akshata Moghe United States 12 44 0.1× 70 0.3× 408 1.8× 44 0.2× 88 0.6× 30 952
W. Kuhnz Germany 23 79 0.2× 44 0.2× 220 1.0× 227 1.1× 138 1.0× 70 1.6k
S GEORGE United Kingdom 17 165 0.5× 35 0.1× 152 0.7× 34 0.2× 35 0.3× 27 774
Peter H. Bach United Kingdom 19 65 0.2× 75 0.3× 338 1.5× 284 1.3× 134 1.0× 70 1.1k
Daniela Keller Germany 13 144 0.4× 90 0.4× 235 1.1× 110 0.5× 164 1.2× 17 791

Countries citing papers authored by Greg Bondy

Since Specialization
Citations

This map shows the geographic impact of Greg Bondy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Bondy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Bondy more than expected).

Fields of papers citing papers by Greg Bondy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Bondy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Bondy. The network helps show where Greg Bondy may publish in the future.

Co-authorship network of co-authors of Greg Bondy

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Bondy. A scholar is included among the top collaborators of Greg Bondy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Bondy. Greg Bondy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kwok, Kevin W.H., et al.. (2022). Risk Factors, Screening, Diagnosis, and Treatment of Osteoporosis in HIV-Infected Adults in an HIV Primary Care Clinic. The Canadian Journal of Hospital Pharmacy. 75(3). 178–185.
2.
Saeedi, Ramesh, et al.. (2010). Ankle Brachial Index Screening for Occult Vascular Disease Is Not Useful in HIV-Positive Patients. AIDS Research and Human Retroviruses. 26(9). 955–959. 12 indexed citations
3.
Normén, Lena, Benita Yip, Julio Montaner, et al.. (2007). Use of metabolic drugs and fish oil in HIV‐positive patients with metabolic complications and associations with dyslipidaemia and treatment targets. HIV Medicine. 8(6). 346–356. 10 indexed citations
4.
Tildesley, Hugh D., et al.. (2006). Sulfonylurea therapy is associated with increased NT-proBNP levels in the treatment of type 2 diabetes. International Journal of Cardiology. 115(3). 312–317. 6 indexed citations
5.
Robinson, Claire, et al.. (2006). Does the albumin:creatinine ratio lack clinical utility in predicting microalbuminuria?. 4 indexed citations
6.
Chan, Keith, Paula Braitstein, Aranka Anema, et al.. (2005). Food Insecurity and Hunger Are Prevalent among HIV-Positive Individuals in British Columbia, Canada. Journal of Nutrition. 135(4). 820–825. 146 indexed citations
7.
Levy, Adrian R., Lawrence C. McCandless, P. Richard Harrigan, et al.. (2005). Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS. Lipids in Health and Disease. 4(1). 4–4. 35 indexed citations
8.
Normén, Lena, et al.. (2004). Combination Therapy With Fenofibrate and Rosiglitazone Paradoxically Lowers Serum HDL Cholesterol. Diabetes Care. 27(9). 2241–2242. 24 indexed citations
9.
Kingsbury, Kori & Greg Bondy. (2003). Understanding the Essentials of Blood Lipid Metabolism. Progress in Cardiovascular Nursing. 18(1). 13–18. 13 indexed citations
10.
Heath, Katherine, Julio Montaner, Greg Bondy, et al.. (2003). Emerging Drug Toxicities of Highly Active Antiretroviral Therapy for HumanImmunodeficiency Virus (HIV) Infection. Current Drug Targets. 4(1). 13–22. 28 indexed citations
11.
Keicho, Naoto, Yuji Higashimoto, Greg Bondy, et al.. (1999). Endotoxin-specific NF-κB activation in pulmonary epithelial cells harboring adenovirus E1A. American Journal of Physiology-Lung Cellular and Molecular Physiology. 277(3). L523–L532. 31 indexed citations
12.
Hayashi, Shizu, I.C. Gillam, Greg Bondy, Vincent Duronio, & James C. Hogg. (1995). Molecular mechanisms of sepsis: Molecular biology of the cell. Journal of Critical Care. 10(2). 82–95. 7 indexed citations
13.
Bai, T R, Todd H. Weir, Blair Walker, et al.. (1995). Substance P (NK1)- and neurokinin A (NK2)-receptor gene expression in inflammatory airway diseases. American Journal of Physiology-Lung Cellular and Molecular Physiology. 269(3). L309–L317. 119 indexed citations
14.
Wilkins, G E, et al.. (1995). Oncogenic osteomalacia: evidence for a humoral phosphaturic factor.. The Journal of Clinical Endocrinology & Metabolism. 80(5). 1628–1634. 87 indexed citations
15.
Bondy, Greg. (1991). Phorbol ester, forskolin, and serum induction of a human colon nuclear hormone receptor gene related to the NUR 77/NGFI-B genes.. PubMed. 2(4). 203–8. 15 indexed citations
16.
Okey, Allan B., Greg Bondy, Michelle E. Mason, et al.. (1980). Temperature-dependent cytosol-to-nucleus translocation of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in continuous cell culture lines.. Journal of Biological Chemistry. 255(23). 11415–11422. 198 indexed citations
17.
Okey, Allan B., Greg Bondy, Michelle E. Mason, et al.. (1979). Regulatory gene product of the Ah locus. Characterization of the cytosolic inducer-receptor complex and evidence for its nuclear translocation.. Journal of Biological Chemistry. 254(22). 11636–11648. 346 indexed citations
18.
Bondy, Greg & Allan B. Okey. (1978). Estrogen Binding in Mammary Tissue of C3H Mice With or Without the Mouse Mammary Tumor Virus. Oncology. 35(3). 127–131. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026